AK Medical (HKG:1789) expects net profit to increase more than 20% in the first half from a year earlier, according to a Tuesday Hong Kong bourse filing.
The company also expects revenue to rise about 10%, with overseas revenue increasing about 40% from the corresponding period of 2025.
AK Medical attributed the expected growth to rapid increases in overseas sales and sales of intelligent devices.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.